Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Hengrui Pharma Partners with Medidata to Accelerate Global Drug Research

By Medidata | November 16, 2018

Hengrui Pharma, a Chinese biopharma company with clinical development programs across oncology, anesthesiology & pain management, autoimmune, and metabolic & cardiovascular diseases, has recently adopted Medidata Cloud, the Intelligent Platform for Life Sciences, to accelerate global drug research.

Hengrui selected the Medidata cloud platform in the third quarter of this year to unify data management and navigate international complexities. With Medidata’s unrivaled global expertise, the company will:

  • Unify clinical trials and reduce risk with a single source for data entry
  • Streamline study operations, planning and execution
  • Automate reporting of adverse events
  • Standardize data on the Medidata Cloud in support of global regulatory compliance requirements

“Medidata will enable us to make a bigger footprint globally and deliver smarter treatments to patients,” said Jianjun Zou, chief medical officer, Hengrui Pharma. “Only Medidata’s comprehensive offerings can support us as we expand our drug therapies to patients around the world. We are confident that Medidata’s exceptional cloud platform and deep understanding of both China and global regions will accelerate our drug development.”

Medidata’s end-to-end solutions provide a clear view into all clinical trial processes, including study planning and execution. 

(Source: Medidata)


Filed Under: Drug Discovery and Development

 

Related Articles Read More >

Portrait photo of Cardinal Health CFO and soon-to-be CEO Jason Hollar
Cardinal Health’s CFO to move up to corner office
CNS
The CNS drug development drum beat is getting louder
DeepMind
7 ways DeepMind’s AlphaFold is being used in life sciences
Biomarker
Bioanalytical method development and validation using Quanterix’s Simoa platform 

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Medtech100 Index
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50